Form D — King Therapeutics LLC
0002088073-25-000001 · filed Oct 15, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Other filings
Offering
- Industry
- Other
- Exemptions
- Rule 506(b)
- Reported offering amount
- $500,000
- Reported amount sold
- $310,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- King Therapeutics LLC
- CIK
- 2088073
- Entity
- Limited Liability Company
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 12006 S. 44TH ST.
PHOENIX, Arizona 85044 - Phone
- 602-516-2199
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
David Richardson · Executive OfficerPhoenix, Arizona Find on LinkedIn ↗
-
Dmitry Derkach · DirectorGilbert, Arizona Find on LinkedIn ↗
-
Isaiah Slemons · DirectorTempe, Arizona Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗